Darya-Varia Laboratoria Tbk PT
IDX:DVLA
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 390
1 810
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one DVLA stock under the Base Case scenario is 2 178.44 IDR. Compared to the current market price of 1 635 IDR, Darya-Varia Laboratoria Tbk PT is Undervalued by 25%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Darya-Varia Laboratoria Tbk PT
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for DVLA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Darya-Varia Laboratoria Tbk PT
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Darya-Varia Laboratoria Tbk PT
Balance Sheet Decomposition
Darya-Varia Laboratoria Tbk PT
Current Assets | 1.6T |
Cash & Short-Term Investments | 437.9B |
Receivables | 724B |
Other Current Assets | 455.9B |
Non-Current Assets | 633.3B |
Long-Term Investments | 37.9B |
PP&E | 459.9B |
Intangibles | 50.2B |
Other Non-Current Assets | 85.4B |
Current Liabilities | 610.4B |
Accounts Payable | 154.1B |
Accrued Liabilities | 372.3B |
Other Current Liabilities | 84B |
Non-Current Liabilities | 163.7B |
Long-Term Debt | 709.4m |
Other Non-Current Liabilities | 163B |
Earnings Waterfall
Darya-Varia Laboratoria Tbk PT
Revenue
|
2.1T
IDR
|
Cost of Revenue
|
-1T
IDR
|
Gross Profit
|
1.1T
IDR
|
Operating Expenses
|
-872.2B
IDR
|
Operating Income
|
252.6B
IDR
|
Other Expenses
|
-58.7B
IDR
|
Net Income
|
193.9B
IDR
|
Free Cash Flow Analysis
Darya-Varia Laboratoria Tbk PT
IDR | |
Free Cash Flow | IDR |
DVLA Profitability Score
Profitability Due Diligence
Darya-Varia Laboratoria Tbk PT's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
Score
Darya-Varia Laboratoria Tbk PT's profitability score is 53/100. The higher the profitability score, the more profitable the company is.
DVLA Solvency Score
Solvency Due Diligence
Darya-Varia Laboratoria Tbk PT's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Score
Darya-Varia Laboratoria Tbk PT's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DVLA Price Targets Summary
Darya-Varia Laboratoria Tbk PT
Dividends
Current shareholder yield for DVLA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
PT Darya-Varia Laboratoria Tbk engages in the manufacture and trade of pharmaceutical products and cosmetics. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,274 full-time employees. Its segments include prescription drugs, consumer health products, and export and toll manufacturing services. The firm provides products and services for consumer health, skin nutrition, respiratory, vitamins and daily relief. The Company’s products include Remscar (silicone gel), Carvilol, Ondavar (antiemetic), Etorix, Forti-D (vitamin D supplement), Decolgen, Neozep, Stop Cold, Decolsin, and Allerin. The Carvilol is used for heart health and treating hypertension. Ondavar is an antiemetic product used for nausea and vomiting during pregnancy. Etorix is a pain reliever. Forti-D is a supplement to fulfill the body’s need for vitamin D3. Darya-Varia provides a range of brands such as Enervon-C, Enervon Active, and Supertin that helps to boost body immune and maintain health. The firm also provides Imunped as supplement for kids with Zinc and vitamin C for children.
Contact
IPO
Employees
Officers
The intrinsic value of one DVLA stock under the Base Case scenario is 2 178.44 IDR.
Compared to the current market price of 1 635 IDR, Darya-Varia Laboratoria Tbk PT is Undervalued by 25%.